Who owns PCRX?
Institutional ownership of Pacira BioSciences Inc. from Form 13F, Q2 2026
253 institutional managers reported holding Pacira BioSciences Inc. (PCRX) in Form 13F filings for Q2 2026, with 43,987,120 shares worth $1.1B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 619,111 shares (+1.4%). 37 opened new positions and 24 sold out.
- Funds holding
- 253
- Value held
- $1.1B
- New / sold out
- 37 / 24
- Net shares, same filers
- +1.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PCRX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $170M | 15.2% | 6,705,809 | Trimmed |
| Doma Perpetual Capital Management LLC | $70.5M | 6.3% | 2,777,794 | Unchanged |
| Vanguard Portfolio Management LLC | $61.0M | 5.5% | 2,406,238 | Trimmed |
| Dimensional Fund Advisors LP | $53.4M | 4.8% | 2,103,245 | Added |
| State Street Corp | $52.3M | 4.7% | 2,059,977 | Added |
| D. E. Shaw & Co., Inc. | $49.5M | 4.4% | 1,950,332 | Trimmed |
| Renaissance Technologies LLC | $44.0M | 3.9% | 1,733,801 | Trimmed |
| Vanguard Capital Management LLC | $42.9M | 3.8% | 1,691,571 | Trimmed |
| Goldman Sachs Group Inc | $38.7M | 3.5% | 1,527,129 | Trimmed |
| Geode Capital Management, LLC | $29.4M | 2.6% | 1,158,693 | Added |
| Morgan Stanley | $29.0M | 2.6% | 1,144,654 | Trimmed |
| American Century Companies Inc | $25.8M | 2.3% | 1,018,093 | Added |
| UBS Group AG | $23.3M | 2.1% | 920,217 | Added |
| Impax Asset Management Group plc | $19.0M | 1.7% | 750,027 | Unchanged |
| Two Sigma Investments, LP | $18.4M | 1.6% | 724,604 | Added |
| Charles Schwab Investment Management Inc | $17.5M | 1.6% | 690,786 | Trimmed |
| Gagnon Securities LLC | $15.4M | 1.4% | 608,617 | Trimmed |
| LSV Asset Management | $15.4M | 1.4% | 608,376 | Added |
| Wellington Management Group LLP | $14.3M | 1.3% | 563,458 | Added |
| Northern Trust Corp | $13.4M | 1.2% | 526,782 | Added |
| Bridgeway Capital Management, LLC | $10.4M | 0.9% | 411,373 | Unchanged |
| Deutsche Bank Ag\ | $9.9M | 0.9% | 391,101 | Trimmed |
| Jefferies Financial Group Inc. | $9.4M | 0.8% | 370,092 | Added |
| Hillsdale Investment Management Inc. | $9.2M | 0.8% | 362,700 | Added |
| Gagnon Advisors, LLC | $8.9M | 0.8% | 352,637 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 43,987,120 PCRX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- UBS Group AG Added+$9.1M
- Pacer Advisors, Inc. New+$5.4M
- Assenagon Asset Management S.A. New+$5.1M
- Two Sigma Investments, LP Added+$5.0M
- American Century Companies Inc Added+$4.6M
- Millennium Management LLC Added+$4.5M
- Jefferies Financial Group Inc. Added+$4.4M
- State Street Corp Added+$3.6M
- Cambridge Investment Research Advisors, Inc. Added+$3.4M
- Marshall Wace, LLP New+$3.3M
Biggest sellers in Q2 2026
- Citadel Advisors LLC Trimmed-$16.1M
- First Trust Advisors LP Trimmed-$7.4M
- Morgan Stanley Trimmed-$6.3M
- Jane Street Group, LLC Sold out-$3.2M
- Prudential Financial Inc Trimmed-$2.6M
- Phocas Financial Corp. Sold out-$2.6M
- Vanguard Portfolio Management LLC Trimmed-$2.4M
- Balyasny Asset Management L.P. Sold out-$2.4M
- Vanguard Capital Management LLC Trimmed-$2.3M
- Renaissance Technologies LLC Trimmed-$2.3M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $92.1M and sold $74.6M; 80 added and 83 trimmed.
Schedule 13D and 13G filings on PCRX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-07STATE STREET CORP SCHEDULE 13G filed by Pacira BioSciences Inc.Schedule 13G
- 2026-04-09DIMENSIONAL FUND ADVISORS LP SCHEDULE 13G filed by Pacira BioSciences Inc.Schedule 13G
- 2025-08-13RENAISSANCE TECHNOLOGIES LLC SCHEDULE 13G filed by Pacira BioSciences Inc.Schedule 13G
- 2025-01-15MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Pacira BioSciences Inc.Schedule 13G
Questions about PCRX ownership
- Who owns PCRX stock?
- 253 institutional investment managers reported PCRX positions in their Form 13F filings for Q2 2026, holding 43,987,120 shares worth $1.1B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling PCRX?
- In Q2 2026, 37 managers opened new PCRX positions, 80 added, 83 trimmed and 24 sold out. Managers that filed in both quarters added a net 619,111 shares.
- How current is this PCRX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PCRX by CUSIP. Options are left out. PCRX news and filings · PCRX insider trades · Top funds